<DOC>
	<DOC>NCT00990015</DOC>
	<brief_summary>The purpose of this study is to determine the safety, tolerability, pharmacokinetics (understanding how a drug is absorbed and moves through the body) and pharmacodynamics (understanding the effects of a drug on certain target sites of activity in the body).</brief_summary>
	<brief_title>A Phase 1 Single-Dose Escalation Study of PF-04308515 in Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy males between 18 and 55 years, inclusive Healthy females between 18 and 44 years, inclusive. Women need to be surgically sterile Evidence or history of clinically significant disease Postmenopausal women History of intolerance or significant adverse effects with glucocorticoids</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Safety; tolerability; pharmacokinetics/pharmacodynamics</keyword>
</DOC>